ClinicalTrials.gg
Drug

Cabotegravir clinical trials

Also written GSK1265744, Apretude and Vocabria.

studies test it
60
open now
9
in phase 3
17
first study started
2008

Counted the way a researcher would: Cabotegravir with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses cabotegravir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the cabotegravir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Jan 2021 · VOCABRIA · NDA 212887 (FDA, Drugs@FDA)
European Union
17 Dec 2020 · Vocabria · EMEA/H/C/004976 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

CAB LA
10
Cabotegravir
7
Cabotegravir (CAB) tablet
3
Cabotegravir - Injectable Suspension (CAB LA)
3
Cabotegravir Injectable Suspension
3

Brand

Apretude
6
Vocabria
2

Development codes

GSK1265744
10
Oral 744
1

Studies by the year they started

59 studies that test it; most in 2020 (6); 1 more planned to start later

Studies that test cabotegravir, by start year
YearStudies
20082
20092
20101
20111
20123
20132
20144
20155
20164
20174
20181
20192
20206
20212
20224
20235
20245
20252
20264

By phase

A phase 1/2 study counts in both.

Phase 1
27
Phase 2
12
Phase 3
17
Phase 4
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 40 · Other 20

ViiV Healthcare (37) · National Institute of Allergy and Infectious Diseases (NIAID) (8) · GlaxoSmithKline (2) · Beth Israel Deaconess Medical Center (1) · University of Witwatersrand, South Africa (1) · University of California, San Francisco (1) · Janssen Research & Development, LLC (1) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1)

Often tested with

Tested in the same studies.

Rilpivirine (8) · Tenofovir (2) · Emtricitabine (2) · Dolutegravir (2) · Lamivudine (1) · Rifabutin (1) · Midazolam (1) · Lenacapavir (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Cabotegravir is the comparator. A study of two new drugs counts under both.

  • 1Lenacapavir · Gilead Sciences · next primary completion Mar 2029
  • 1Teropavimab · Gilead Sciences · next primary completion Mar 2029
  • 1Zinlirvimab · Gilead Sciences · next primary completion Mar 2029
Reaching primary completion within a year · 2

Studies that test cabotegravir.

Studies

Open first, then newest update. How each study uses cabotegravir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 60

See all 60 studies that test cabotegravir →

Given beside what is tested · 4 — cabotegravir is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with cabotegravir

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call cabotegravir · ClinicalTrials.gg INT006392

  • MeSH (NLM) C584914cabotegravirConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) HMH0132Z1QCABOTEGRAVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 2475077One source FDA
  • Wikidata Q15411012cabotegravirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C169820CabotegravirOne source FDA
  • DrugBank DB11751One source Wikidata

Also registered as cabotegravir sodium (UNII 3L12PT535M · RxNorm 2475076).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.